Viewing Study NCT01085656


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-10 @ 3:03 PM
Study NCT ID: NCT01085656
Status: TERMINATED
Last Update Posted: 2017-08-08
First Post: 2010-03-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Clinical Trial of OXi4503 for Relapsed and Refractory AML and MDS
Sponsor: University of Florida
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myelogenous, Acute View
None Myelodysplastic Syndromes View
Keywords: